Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Nephrology · Autosomal Dominant Tubulointerstitial Kidney Disease–UMOD

Inheritance and the Impact on Your Family

At a Glance

ADTKD-UMOD is inherited in an autosomal dominant pattern: each child of a person with a disease-causing UMOD variant has a 50% chance of inheriting it. Genetic counseling and targeted family testing can guide monitoring, kidney donation, and family-planning decisions.

Because ADTKD-UMOD is a genetic condition, your diagnosis has implications that reach beyond your own health. Understanding how the disease is passed down and how it might affect your relatives is the first step in protecting your family’s future [1].

The 50/50 Rule: Autosomal Dominant Inheritance

ADTKD-UMOD follows a pattern called autosomal dominant inheritance. This means that a person only needs one mutated copy of the UMOD gene to develop the disease [2].

  • The Odds: For every pregnancy, there is a 50% chance (1 in 2) that the mutation will be passed to the child [3].
  • No “Skip”: The inheritance pattern does not “skip” generations. If a child does not inherit the mutation, they cannot pass it on to their own children. However, the clinical signs may appear to skip a generation because of late onset, variable severity, or an unrecognized affected parent [1].
  • “De Novo” Cases: In some cases, a person may be the first in their family to have the mutation. This is called a de novo mutation, meaning it started with you rather than being inherited from a parent [4][5].

Men vs. Women: Differences in Progression

While both men and women inherit the gene at the same rate, the disease often moves faster in men [6].

  • Timing of Kidney Failure: In large studies, the median age for reaching kidney failure was 47 years [6].
  • The “Gap”: On average in these cohorts, men tend to reach this stage about four years earlier than women with the same mutation [7].
  • Variability: It is important to remember that these are averages. In any given family, one person might reach kidney failure at age 30 while another remains healthy into their 70s [4][8]. Current science cannot reliably predict an individual’s exact age of kidney failure from sex or UMOD variant alone.

Why Your Specific Mutation Matters

Not all UMOD mutations are created equal. The speed of your kidney decline is often linked to how severely the mutation causes the uromodulin protein to get “stuck” inside your cells [6][9].

  • “Milder” Variants: Some specific mutations, like one called p.Thr62Pro, are known to cause a slower decline in some research observations [8].
  • Predictive Testing: Scientists use lab scores to measure how much a mutation disrupts protein traffic. These scores are currently experimental research tools, not validated tests that reliably predict your individual outcome [6].

Knowing Your Subtype: Typical Clues

When you tell doctors you have ADTKD, they may check your records for other subtypes. Having a confirmed UMOD mutation explains your diagnosis, but here are the typical clues of other subtypes:

  • ADTKD-MUC1: Often looks identical to UMOD but usually doesn’t cause gout [10]. It requires a very specialized genetic test [11].
  • ADTKD-REN: Often starts in childhood and can cause low blood pressure, anemia, and high potassium [12][2].
  • ADTKD-HNF1B: Often involves other organs, such as the pancreas (causing diabetes) or structural issues like cysts or unusual kidney shapes [13][14].

Family Planning and Future Generations

If you are planning to start or grow a family, preconception counseling is important.

  • Preimplantation Genetic Testing (PGT-M): This involves using IVF (In Vitro Fertilization) to test embryos for the UMOD mutation before they are implanted, to reduce the chance of transmitting the known variant. It requires test development, genetic counseling, and does not guarantee a healthy pregnancy or child [15].
  • Natural Conception: Many families choose natural conception. However, chronic kidney disease can increase risks of maternal hypertension, preeclampsia, fetal-growth restriction, and kidney-function decline [16]. Preconception review with your nephrology team and maternal-fetal medicine is strongly recommended.

Cascade Testing: Reaching Out to Relatives

“Cascade testing” is the process of offering targeted testing to at-risk relatives once a mutation is found in the family [17].

  • Who to Test: Testing usually starts with “first-degree” relatives—parents, siblings, and adult children [18].
  • The Benefit: Most people (93%) who are found to have the mutation through family testing say they are glad they did it [18]. It allows for early monitoring and is vital for identifying who can safely serve as a kidney donor [17][18].
  • Counseling: Independent genetic counseling should precede testing to discuss the right not to know, privacy concerns, potential impacts on life or disability insurance, and to protect family members from undue pressure regarding living donation.
  • Minors: Testing children is a personal decision. While the disease rarely causes major issues in early childhood, knowing a child’s status can help avoid “diagnostic odysseys” if they develop gout or high uric acid as teenagers [5][2].

Common questions in this guide

What is the chance of passing ADTKD-UMOD to my child?
ADTKD-UMOD is autosomal dominant, meaning one altered copy of the UMOD gene can cause the condition. If you carry the disease-causing variant, each pregnancy has a 50% chance of inheriting it, regardless of earlier pregnancies or the child’s sex.
Can ADTKD-UMOD skip a generation?
The UMOD variant itself does not skip generations: a child who does not inherit it cannot pass it to their own children. The condition can look as if it skipped a generation when symptoms start late, vary in severity, or an affected parent was never diagnosed.
Should my relatives get tested for the UMOD variant?
Genetic counseling and targeted testing are commonly offered first to parents, siblings, and adult children of someone with a confirmed UMOD variant. Normal kidney blood tests do not always rule out the variant, and knowing the result can guide monitoring and living-donor decisions.
Can my UMOD variant predict when my kidneys will fail?
The exact variant may be associated with faster or slower kidney decline, and studies have reported a median age of kidney failure around 47 years in some groups. However, people in the same family can reach kidney failure decades apart, and sex or the UMOD variant alone cannot reliably predict an individual’s timing.
What family-planning options are available if I have ADTKD-UMOD?
Preconception counseling with your nephrology team and a maternal-fetal medicine specialist can review pregnancy risks and your kidney function. IVF with preimplantation genetic testing, called PGT-M, can test embryos for the known UMOD variant before implantation, but it requires specialized planning and does not guarantee a healthy pregnancy or child.
When should a child in an ADTKD-UMOD family be tested?
There is no single age that fits every family, so the decision should be made with a genetic counselor and the child’s clinician. Because serious kidney problems are uncommon in early childhood but gout or high uric acid may appear in adolescence, testing can sometimes prevent delays in recognizing the condition.
Should a potential living kidney donor in my family have UMOD testing?
An at-risk relative who may donate a kidney should be evaluated for the family’s specific UMOD variant before donation decisions are made. Genetic counseling can help protect the donor’s long-term health, explain privacy issues, and reduce pressure on family members.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific UMOD mutation, does the research suggest a faster or slower progression compared to the median age of 47?
  2. 2.Can you refer me to a genetic counselor to discuss the risk to my children and options for family planning?
  3. 3.Should my siblings or adult children be screened with a genetic test, even if their blood work currently looks normal?
  4. 4.If we decide to test my children, at what age should that begin, and what would we do differently if the test is positive?
  5. 5.How can we ensure that any family members who want to be kidney donors are tested for my specific mutation first?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Autosomal Dominant Tubulointerstitial Kidney Disease.

    Bleyer AJ, Kidd K, Živná M, Kmoch S

    Advances in chronic kidney disease 2017; (24(2)):86-93 doi:10.1053/j.ackd.2016.11.012.

    PMID: 28284384
  2. 2

    Autosomal dominant tubulointerstitial kidney disease: A review.

    Živná M, Kidd KO, Barešová V, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(3)):309-324 doi:10.1002/ajmg.c.32008.

    PMID: 36250282
  3. 3

    Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

    Eckardt KU, Alper SL, Antignac C, et al.

    Kidney international 2015; (88(4)):676-83 doi:10.1038/ki.2015.28.

    PMID: 25738250
  4. 4

    ADTKD-UMOD in a girl with a de novo mutation: A case report.

    Li MS, Li Y, Jiang L, et al.

    Frontiers in medicine 2022; (9()):1077655 doi:10.3389/fmed.2022.1077655.

    PMID: 36606057
  5. 5

    Early-onset kidney failure in a girl with autosomal dominant tubulointerstitial kidney disease due to a de novo UMOD variant.

    Tomori S, Miura K, Shirai Y, et al.

    CEN case reports 2026; (15(2)):46 doi:10.1007/s13730-025-01081-3.

    PMID: 41642419
  6. 6

    Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations.

    Kidd K, Vylet'al P, Schaeffer C, et al.

    Kidney international reports 2020; (5(9)):1472-1485 doi:10.1016/j.ekir.2020.06.029.

    PMID: 32954071
  7. 7

    Quantifying clinical and genetic factors influencing rate and severity of autosomal dominant tubulointerstitial kidney disease progression.

    Ramesh SS, Rogge M, Kidd KO, et al.

    Journal of pharmacokinetics and pharmacodynamics 2025; (52(4)):41.

    PMID: 40707830
  8. 8

    An intermediate-effect size variant in UMOD confers risk for chronic kidney disease.

    Olinger E, Schaeffer C, Kidd K, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2022; (119(33)):e2114734119 doi:10.1073/pnas.2114734119.

    PMID: 35947615
  9. 9

    Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease.

    Schiano G, Lake J, Mariniello M, et al.

    EMBO molecular medicine 2023; (15(12)):e18242 doi:10.15252/emmm.202318242.

    PMID: 37885358
  10. 10

    Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.

    Ayasreh N, Bullich G, Miquel R, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(3)):411-418 doi:10.1053/j.ajkd.2018.03.019.

    PMID: 29784615
  11. 11

    Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutation: A Two-Case Report and Literature Review.

    Liang D, Liang S, Zhang M, et al.

    Nephron 2019; (143(4)):282-287 doi:10.1159/000502146.

    PMID: 31422399
  12. 12

    An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes.

    Živná M, Kidd K, Zaidan M, et al.

    Kidney international 2020; (98(6)):1589-1604 doi:10.1016/j.kint.2020.06.041.

    PMID: 32750457
  13. 13

    Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease.

    Izzi C, Dordoni C, Econimo L, et al.

    Kidney international reports 2020; (5(12)):2341-2350 doi:10.1016/j.ekir.2020.09.042.

    PMID: 33305128
  14. 14

    Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.

    Bleyer AJ, Wolf MT, Kidd KO, et al.

    Pediatric nephrology (Berlin, Germany) 2022; (37(5)):933-946 doi:10.1007/s00467-021-05118-4.

    PMID: 34021396
  15. 15

    A comprehensive PGT-M strategy for ADPKD patients with de novo PKD1 mutations using affected embryo or gametes as proband.

    Wang Y, Zhai F, Guan S, et al.

    Journal of assisted reproduction and genetics 2021; (38(9)):2425-2434 doi:10.1007/s10815-021-02188-z.

    PMID: 33939064
  16. 16

    Maternal health and pregnancy outcomes in autosomal dominant tubulointerstitial kidney disease.

    Bleyer AJ, Kidd KO, Williams AH, et al.

    Obstetric medicine 2023; (16(3)):162-169 doi:10.1177/1753495X221133150.

    PMID: 37720000
  17. 17

    Identification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease.

    Lopes LB, Abreu CC, Souza CF, et al.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica 2018; (51(3)):e6560 doi:10.1590/1414-431X20176560.

    PMID: 29513881
  18. 18

    Quality of life in patients with autosomal dominant tubulointerstitial kidney disease
.

    Bleyer AJ, Kidd K, Johnson E, et al.

    Clinical nephrology 2019; (92(6)):302-311 doi:10.5414/CN109842.

    PMID: 31587753

This page is for informational purposes only and does not constitute medical advice. A nephrologist and genetic counselor can help interpret your UMOD result and discuss family testing, pregnancy, and kidney-donation decisions.

Get notified when new evidence is published on familial juvenile hyperuricemic nephropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.